EGR3 Promotes Glioblastoma Cell Growth with Upregulation of MYC and CDK1
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26135931 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chia-Wei Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan. Hauptthemen laut MEDLINE: Glioblastoma, Proto-Oncogene Proteins c-myc, CDC2 Protein Kinase, Early Growth Response Protein 3. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Medical Foundation, National Science and Technology Council, Taiwan, Chang Gung Medical Foundation and Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumor, characterized by rapid growth and resistance to therapy. Despite extensive research, the molecular mechanisms driving GBM progression remain incompletely understood. In this study, we employed integrative transcriptomic analysis to identify transcription factors associated with GBM, revealing EGR3 as a key candidate. Functional assays demonstrated that EGR3 promotes GBM cell viability, with EGR3 overexpression significantly enhancing cell growth, while EGR3 disruption impaired viability. To elucidate the downstream targets of EGR3, we further performed transcriptomic analysis and identified MYC and CDK1 as significantly upregulated in response to EGR3 overexpression. These results suggest that EGR3 is associated with enhanced GBM cell growth, potentially through the regulation of MYC and CDK1. Our findings provide a clear model linking EGR3 to GBM proliferation and highlight MYC and CDK1 as potential therapeutic targets. This study advances the understanding of transcription factor-associated oncogenesis in GBM and suggests that targeting EGR3 may offer a novel therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan.
- Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou Medical Center, Taoyuan 333423, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan.
- Neuroscience Research Center, Chang Gung Memorial Hospital, Linkou, Taoyuan 333423, Taiwan.
ORCID-Profile: Yi-Chuan Cheng
Förderung
- Chang Gung Medical Foundation
- National Science and Technology Council, Taiwan
- Chang Gung Medical Foundation and Chang Gung Memorial Hospital
Zitieren
APA
Chang, C. W., Chou, Y. C., Huang, Y. C., & Cheng, Y. C. (2025). EGR3 Promotes Glioblastoma Cell Growth with Upregulation of MYC and CDK1. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135931
Vancouver
Chang CW, Chou YC, Huang YC, Cheng YC. EGR3 Promotes Glioblastoma Cell Growth with Upregulation of MYC and CDK1. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135931
BibTeX
@article{Chang2025,
author = {Chang, Chia-Wei and Chou, Yi-Chin and Huang, Yin-Cheng and Cheng, Yi-Chuan},
title = {EGR3 Promotes Glioblastoma Cell Growth with Upregulation of MYC and CDK1},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26135931}
}
EUVIMED